Despite good evidence to show that good glycaemic control early in the disease history results in better outcomes for people with type 2 diabetes, glycaemic control is demonstrably suboptimal in type 2 patients all around the world. One leading culprit implicated in this phenomenon is therapeutic inertia. Through a Q&A session between one of the UK’s leading experts on therapeutic inertia and leading primary care physicians from across Europe, this module addresses key questions about this important aspect of diabetes care.
By the end of this module, you will be able to:
✓ Explain the impact of therapeutic inertia and the consequences for patients with diabetes
✓ Identify the barriers to optimal care and the typical profile of inertia-prone patients
✓ Plan the optimal treatment for patients with diabetes to overcome therapeutic inertia
This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.